These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8161370)

  • 21. [Septic shock in newborn infants].
    Mancilla-Ramírez J
    Bol Med Hosp Infant Mex; 1992 Nov; 49(11):766-76. PubMed ID: 1466777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traumatic and septic shock alias post-trauma critical illness.
    Hardaway RM
    Br J Surg; 1998 Nov; 85(11):1473-9. PubMed ID: 9823905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sepsis syndrome: progress and therapeutic perspectives].
    Schaller MD
    Schweiz Med Wochenschr; 1992 May; 122(20):768-75. PubMed ID: 1604283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
    Martínez C; Juarranz Y; Abad C; Arranz A; Miguel BG; Rosignoli F; Leceta J; Gomariz RP
    J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation in septic shock due to gram-negative and gram-positive bacteria.
    León C; Rodrigo MJ; Tomasa A; Gallart MT; Latorre FJ; Rius J; Brugués J
    Crit Care Med; 1982 May; 10(5):308-10. PubMed ID: 6918253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii.
    Miech RP
    Ann Pharmacother; 2005 Sep; 39(9):1483-8. PubMed ID: 16046483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory cytokine levels in patients with septic shock.
    Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lysosomal enzymes in experimental and clinical endotoxemia.
    Godin DV; Wright JM; Tuchek JM; Scudamore CH
    Clin Invest Med; 1983; 6(4):319-25. PubMed ID: 6671362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of cell adhesion molecules and proinflammatory mediators in the pathogenesis of endotoxin adult respiratory distress syndrome].
    Lazarov S; Balutsov M; Ianev E
    Vutr Boles; 2000; 32(4):18-24. PubMed ID: 11688326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of gram-negative sepsis.
    Dudley MN
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S3-6. PubMed ID: 2275477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physiopathology of myocardial dysfunction in septic shock].
    Thyrault M; Chemla D; Coirault C; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1993 Mar; 86(3):349-57. PubMed ID: 8215770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Present possibilities of therapy of septic shock in surgical patients].
    Vyhnánek F; Lochmann O
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):105-15. PubMed ID: 1339601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sepsis and organ failure--its pathogenesis and treatment].
    Hanasawa K; Kodama M
    Nihon Geka Gakkai Zasshi; 1998 Aug; 99(8):523-7. PubMed ID: 9789288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
    Roger T; Glauser MP; Calandra T
    J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and humoral mediators of sepsis syndrome.
    Stroud M; Swindell B; Bernard GR
    Crit Care Nurs Clin North Am; 1990 Jun; 2(2):151-60. PubMed ID: 2192724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.